Bone Marrow Failure Syndromes: Clinical Trials

10 trials for Bone Marrow Failure Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 terminated, 1 withdrawn. 10 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 6, Recruiting 2, Terminated 1, Withdrawn 1
Phase 15Completed 2, Recruiting 2, Withdrawn 1

Follow Bone Marrow Failure Syndromes: new trials by email Literature Review of Bone Marrow Failure Syndromes trials Research Report on Bone Marrow Failure Syndromes

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias
Phase 1 / Phase 2RecruitingDren Bio602026-08-142026-11-04
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Fludarabine, Cyclophosphamide, MMF - Acute Leukemia, Acute Myeloid Leukemia
Phase 2CompletedMasonic Cancer Center, University of Minnesota152017-05-152025-07-04
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
RIC regimen, GVHD prophylaxis regimen - Severe Sickle Cell Disease, Bone Marrow Failure Syndromes
Phase 1 / Phase 2RecruitingWashington University School of Medicine292017-03-202026-05-29
Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases
Treosulfan, Busilvex - Primary Immunodeficiencies, Inborn Errors of Metabolism
Phase 2Completedmedac GmbH1062015-04-012025-12-08
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
CD45RA-depleted peripheral blood mononuclear cells - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute
Phase 1 / Phase 2CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology302014-08-012016-04-22
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
Bone marrow transplant, Thymoglobulin, Fludarabine - Severe Aplastic Anemia, Bone Marrow Failure Syndromes
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins182014-08-012023-03-10
Nandrolone Decanoate in the Treatment of Telomeropathies
Nandrolone Decanoate - Aplastic Anemia, Bone Marrow Failure Syndromes
Phase 1 / Phase 2CompletedUniversity of Sao Paulo202014-02-012023-08-31
Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases
CliniMACs device - Bone Marrow Failure Syndromes, Immunodeficiencies
Phase 2CompletedChildren's Hospital of Philadelphia22011-11-012018-04-11
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Enriched Hematopoetic Stem Cell Infusion - Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies
Phase 1 / Phase 2WithdrawnTalaris Therapeutics Inc.2011-05-012023-03-03
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
UDAlloSCT, Therapy - Leukemia, Lymphoma
Phase 2TerminatedColumbia University222002-11-012015-04-15

Narrower conditions

Bone Marrow Failure Disorders (10)  ·  Anemia, Aplastic (3)  ·  Anemia, Sickle Cell (2)  ·  Graft vs Host Disease (2)  ·  Hemoglobinopathies (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Anemia, Diamond-Blackfan (1)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Hematologic Diseases (1)  ·  Histiocytosis (1)  ·  Hodgkin Disease (1)  ·  Idiopathic Pulmonary Fibrosis (1)

Broader conditions

Bone Marrow Diseases (10)  ·  Hemic and Lymphatic Diseases (10)  ·  Hematologic Diseases (9)  ·  Anemia (5)  ·  Immune System Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Disease Attributes (2)

Interventions

Cyclophosphamide (2)  ·  Mycophenolic Acid (2)  ·  fludarabine (2)  ·  Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Mesna (1)  ·  Nandrolone Decanoate (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)  ·  Therapeutics (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)  ·  thymoglobulin (1)  ·  treosulfan (1)

Sponsors

Children's Hospital of Philadelphia (1)  ·  Columbia University (1)  ·  Dren Bio (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  Talaris Therapeutics Inc. (1)  ·  University of Sao Paulo (1)  ·  Washington University School of Medicine (1)  ·  medac GmbH (1)

Countries

United States (7)  ·  Brazil (1)  ·  Czechia (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Amy DeZern, MD (1)  ·  Ana Beatriz Hortense, MD (1)  ·  Karl-Walter Sykora, MD and Prof (1)  ·  Margaret MacMillan, MD, MSC (1)  ·  Michael Maschan, MD (1)  ·  Mitchell S Cairo, MD (1)  ·  Nancy Bunin, MD (1)  ·  Rodrigo T Calado, MD, PhD (1)  ·  Shalini Shenoy, MD (1)  ·  Suzanne T Ildstad, MD (1)  ·  Wan-Jen Hong, MD (1)

Results publications

PMID 32343796, PMID 32813873, PMID 36579443